/UKCI2015-side-effects

The R work described in our conference paper presented at UKCI-2015 in Exeter, 7th-9th Sept. Drug development is a lengthy and highly costly endeavor, often with limited success and high risk. The objective of drug repositioning is to apply existing drugs to different diseases or medical conditions than the original target, and thus alleviate to a certain extent the time and cost expended.

Primary LanguageRMIT LicenseMIT

Stargazers